Signs and symptoms of vulvovaginal atrophy (VVA) in clinical practice – the possible involvement of thyroid autoimmunity in genitourinary syndrome of menopause (GSM)
Background Thyroid autoimmune disorders (ADs) are common in midlife women and can impact various aspects of health, including sexual function. The effect of thyroid autoimmunity on the clinical manifestations of vulvovaginal atrophy (VVA) remains unclear.Objective To explore the relationship between...
Saved in:
| Main Authors: | Laura Cucinella, Federica Barbagallo, Mariacristina Erroi, Chiara Procaccianti, Ellis Martini, Lara Tiranini, Giorgia E. Parrotta, Greta Monne, Giulia M. Colombo, Aldo Calogero, Rossella E. Nappi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Gynecological Endocrinology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09513590.2025.2458705 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vulvovaginal atrophy: current methods of diagnosis and treatment
by: L. F. Zainetdinova, et al.
Published: (2024-04-01) -
Vulvovaginal atrophy: modern approaches to diagnostics and management
by: V. H. Siusiuka, et al.
Published: (2024-01-01) -
An open, single center, clinical investigation to evaluate the efficacy and safety of a non-hormonal vaginal moisturizer for the symptomatic treatment of vulvovaginal atrophy in postmenopausal woman
by: Manuel Sánchez-Prieto, et al.
Published: (2025-12-01) -
The Efficacy of Fractional CO2 Laser in the Treatment of Genitourinary Syndrome of Menopause: A Large Prospective Observational Study
by: Violante Di Donato, et al.
Published: (2022-09-01) -
Treatment of postmenopausal vulvovaginal atrophy with estriol: a scientific update for 2014–2018
by: A. D. Makatsariya, et al.
Published: (2019-09-01)